AKRO
NASDAQ
$54.65
Akero Therapeutics Inc (AKRO)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$4.38B
EPS 5Y CAGR
+23.96%
FCF 5Y CAGR
+33.41%
Free Cash Flow Yield
-5.71%
Price Chart
Valuation
Market Cap$4.38B
Profitability
EBITDA-$471M
EPS-$6.27
Financial Health
Free Cash Flow Yield-5.71%
Growth & Risk
EPS 5Y CAGR+23.96%
FCF 5Y CAGR+33.41%
Sharpe Ratio0.91